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Abstract
Background: Innate immunity of which Toll-like receptor (TLR) 4 and CXCR1 are key elements plays a central role in the
development of urinary tract infection (UTI). Although the relation between the genetics of TLR4 and CXCR1 and UTI is
investigated partly, the polymorphisms and expression of TLR4 and CXCR1 in different types of UTI in adults are not
extremely clear.
Methodology/Principal Findings: This study investigates the presence of TLR4 A (896) G and CXCR1 G (2608) C
polymorphisms in 129 UTI patients using RFLP-PCR. Gene and allelic prevalence were compared with 248 healthy controls.
Flow cytometry was used to detect TLR4 and CXCR1 expression in the monocytes of UTI patients and healthy controls. TLR4
(896) AG genotype and TLR4 (896) G allele had higher prevalence in UTI (especially in acute cystitis and urethritis) patients,
whereas CXCR1 (2608) GC genotype and CXCR1 (2608) C allele had lower prevalence in UTI patients than controls. TLR4
expression was significantly lower in chronic UTI patients than in acute pyelonephritis or healthy controls. CXCR1 expression
was similar in both controls and patients. TLR4 expression in chronic UTI patients after astragalus treatment was higher than
pre-treatment.
Conclusions: The results indicate the relationship between the carrier status of TLR4 (896) G alleles and the development of
UTI, especially acute cystitis and urethritis, in adults. TLR4 expression levels are correlated with chronic UTI.
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Introduction
Urinary tract infections (UTIs) are common infectious dis-
eases,and the non-complex UTI cases show no obvious behavioral,
functional, and structural risk factors. The early response against
UTI is provided by innate immune response, in which, TLR4
plays an important role in activating innate immune response, and
its recognized ligands, such as lipopolysaccharide, have been
demonstrated to initiate anti-UTI responses [1]. TLR4 actions in
bladder cells include promotion of IL-6 and IL-8 secretion by
activation of MyD88-dependent or cAMP-dependent signaling
pathways, and inhibition of bacterial invasion and promotion of
bacterial expulsion in bladder epithelial cells [2–6]. In addition,
neutrophil chemokine receptors, such as CXCR1, are necessary
for neutrophil migration to infected sites [7]and are involved in
innate immune response. CXCR1 is closely correlated with
neutrophil quantity and extent of inflammatory reaction in the
urinary tract.
The individual’s response to UTI is variable and the
susceptibility to the infection is inheritable. Lundstedt et al. found
in a family study, 15% of the relatives of pyelonephritis-prone
children had UTI history, whereas the value was 3% in the
controls [8]. A evaluation of a familal predisposition about women
with recurrent UTI described that 65.5% of mothers, 60.7% of
daughters, and 48.6% of sisters of the women had a similar history
[9]. Many studies discovered that genitic variations of TLR4 and
CXCR1 are association with susceptibility to different type of
UTIs. And TLR4(896)AG genotype and TLR4(896)G alleles
could increase the risk for UTI in childhood [10,11], CXCR1 G
(2608) C gene polymorphism and expression are strong linked to
acute pyelonephritis in children [12]. Reduced expression levels of
CXCR1 and TLR4 in neutrophils are associated with pyelone-
phritis, recurrent cystitis, and asymptomatic bacteriuria in children
and premenopausal women [13–15]. Although these studies
suggest the association of gene polymorphisms and expression of
TLR4 and CXCR1 to UTIs, whether the variants are associated
with UTI in Chinese adults is still unknown, TLR4 and CXCR1
expression levels in different type UTIs is also not clear.
Astragalus is a Chinese herbal medicine, and Astragalus
polysaccharide (APS) is its main compoents. Our previous study
demonstrated that APS could induce enhancement of expression
of TLR4 on bladder epithilial cells [16]. So we hope that
astragalus also increases the TLR4 expression on monocytes in
UTI patients.
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14223In this study, we summarize the results of a case-control study
examing whether polymorphisms and expression in TLR4 and
CXCR1 are associated with susceptibility to acute pyelonephritis,
chronic UTI, and acute cystitis and urethritis in UTI patients in
China, and evaluating whether astragalus can boost innate immnue
respons against UTI through enhancing TLR4 expression.
Results
1. Clinical data
Urinary bacterial strains were identified as follows: E. coli in 109
patients (84.5%); Klebsiella pneumoniae in 5 patients (3.9%); Proteus
mirabilis in 2 patients (1.55%); Morganella morganii in 2 patients
(1.55%); Enterobacter aerogenes in 2 patients (1.55%); Staphylococcus
aureus in 2 patients (1.55%); Enterococcus faecalis in 2 patients
(1.55%); Enterococcus faecium in 3 patients (2.32%); Monilia albicans in
1 patient (0.78%); and Candida glabrata in 1 patient (0.78%).
2. Genotype distribution of TLR4 A (896) G and CXCR1 G
(2608) C
The gene polymorphisms of TLR4 A (896) G and CXCR1G
(2608) C are shown in Table 1. The genotype of TLR4 (896) AG
had higher prevalence among UTI patients than in healthy
controls (p=0.03), and especially TLR4 (896) AG genotype
tended to occur more frequently in acute cystitis and urethritis
patients than in controls (p=0.02). Interestingly the genotype of
CXCR1 (2608) GC had lower prevalence among UTI patients
than in healthy controls (p=0.024). Compared to controls and
acute cystitis and urethritis patients, the genotype of CXCR1
(2608) GC in chronic UTI patients were also lower than the two
groups (p=0.003; 0.016).
3.Allele frequencies of TLR4 (896) G and CXCR1 (2608) C
The prevalence of TLR4 (896) G alleles showed higher in UTI
patients than that in the controls (p=0.034), and the alleles
trended to show more frequently in acute cystitis and urethritis
patients than in the controls (p=0.028). While CXCR1 (2608) C
alleles had lower prevalence in chronic UTI than in the controls
(p=0.003). Compared to acute cystitis and urethritis patients,
chronic UTI patients also had lower CXCR1 (2608)C allele
prevalence (p=0.003) (Table 2).
4. TLR4 expression levels in monocytes in different types
of UTI
The percentage of TLR4 expression in healthy controls, chronic
UTI patients, and acute pyelonephritis patients was 8.5762.88,
5.163.11 and 9.463.1%, respectively. TLR4 expression in
monocytes in patients with chronic UTI was significantly lower
Table 1. Genotypic frequencies at the TLR4 A(896)G andCXCR1G(2608)C polymorphisms in patients suffering UTI compared with
healthy reference populations.
Group No. TLR4A(896)G CXCR1G(2608)C
AA AG GG GG GC CC
healthy controls 248 227(91.5%) 21(8.5%) 0(0%) 196(79%) 50(20.2%) 2(0.8%)
UTI patients total 129 109(84.5%) 20*(15.5%) 0(0%) 111(86.1%) 15
#(11.6%) 3(2.3%)
Patients with acute pyelonephritis 32 29(90.6%) 3(9.4%) 0(0%) 28(87.5%) 3(9.4%) 1(3.1%)
Patients with Chronical UTI 38 32(84.2%) 6(15.8%) 0(0%) 37(97.4%) 1
{(2.6%) 0(0%)
Patients with Acute cystitis and urethritis 59 48(81.4%) 11**(18.6%) 0(0%) 46(78%) 11
{(18.6%) 2(3.4%)
*p=0.03vs healthy controls;
**p=0.024vs healthy controls;
#p=0.024vs healthy controls;
{p=0.003vs healthy controls;
{p=0.016 vs chronical UTIs.
doi:10.1371/journal.pone.0014223.t001
Table 2. Allelic frequencies at the TLR4 A(896)G andCXCR1G(2608)C polymorphisms in patients suffering UTI compared with
healthy reference populations.
Group No. TLR4A(896)G CXCR1G(2608)C
AG G C
healthy controls 248 475(96%) 21(4%) 442(89%) 54(11%)
UTI patients total 129 238(92%) 20*(8%) 237(92%) 21 (8%)
Patients with acute pyelonephritis 32 61(95%) 3(5%) 59(92%) 5(8%)
Patients with Chronical UTI 38 70(92%) 6(8%) 75(99%) 1
{ (1%)
Patients acute cystitis
and urethritis
59 107(91%) 11** (9%) 103(87%) 15
{ (13%)
*p=0.034vs healthy controls;
**p=0.028 vs healthy controls;
{p=0.003 vs healthy controls;
{p=0.003 vs chronical UTIs.
doi:10.1371/journal.pone.0014223.t002
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(p=0.03; 0.03) (Fig. 1).
5. CXCR1 expression levels in neutrophils in different
types of UTI
The percentage of CXCR1 expression in healthy controls,
chronic UTI patients, and acute pyelonephritis patients was
9661.75, 9762.4 and 9761.7%, respectively. There were no
significant differences among these groups (p.0.05) (Fig. 2, Fig. 3).
6. TLR4 expression levels in monocytes before and after
astralagus treatment
The percentage of TLR4 expression in chronic UTI patients
before astralagus treatment (4.162.2%) significantly increased to
17.465.6% post-treatment (p=0.001) (Fig. 4).
Discussion
The relationship between function, expression and gene
mutation of the TLR4 gene and the occurrence of UTI has
interested many researchers. C3H/HeJ mice without response to
LPS (TLR4 mutant mice) couldn’t clear the urinary tract infection.
The reason lay in that they couldn’t make adequate regulation on
pathogens. Maybe this defection was related to TLR4 gene
mutation [17,18,19]Reported studies on children with urinary
tract infection showed that TLR4 gene polymorphism test
indicated gene carrier statuses at TLR4A(896)G allele were
obviously related to recurrent urinary tract infection in children,
while it had no relation with other kidney diseases [11]. Hawn etc.
also carried out polymorphism test of several TLRs of adult
women with 18–49 years old, and found that TLR4A (896) G
Figure 1. The expression levels of TLR4 on monocytes in different types of UTIs. A: Comparation of percent of TLR4 expression in different
types of UTIs. B: The drawing of TLR4 detected by FCM on monocytes of UTI patients. B1: acute pyelonephritis; B2: chronical UTI; B3: health controls.
doi:10.1371/journal.pone.0014223.g001
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pyelonephritis [20]. The results of this study show that the gene
prevalence of TLR4 (896) AG and TLR4 (896) G alleles in UTI
patients is higher than that in the control group, and the gene
prevalence of TLR4 (896) AG and TLR4 (896) G alleles in
patients with acute cystitis and urethritis is higher than that in the
healthy control and acute pyelonephritis groups. These results
indicate that TLR4A(896)G mutation is associated with increased
risk of UTI in adults, especially with acute cystitis and urethritis,
but is not associated with acute pyelonephritis and chronic UTI.
Our data are in line with previous studies, which revealed similar
occurrence of TLR4(896)AG genotype in rUTI in children [11].
But the previous also revealed that TLR4A(896)G polymorphism
was associated with protection from rUTI, but not pyelonephritis
in women 18–49 years old [20]. Obviously, TLR4A(896)G gene
polymorphism are associated with adult susceptibility to UTIs, but
this relationship could vary in different populations and disease
types. Further surveys of more cases and different races are needed
to make conclusive statements.
Acute pyelonephritis and asymptomatic bacteriuria (ABU)
represent the two extremes of UTI respectively. Studies have
shown that TLR42/2 and C3H/HeJ mice lost the function of
TLR4 and could not clear effectively infection, acquired ABU
status, suggesting that the absence of TLR4 signals can make an
infected host appear asymptomatic [18,21]. TLR5 and TLR11
had equal characters [22,23]. But the extreme status was not exist
almost in people. Then their susceptibility to UTI were also
associated with TLR4 expression except polymorphism. Thus, the
relationship between TLR4 expression level and the type of UTI
has become a subject of interest. A survey of ABU children showed
that compared with the healthy group, TLR4 expression level in
the patient group is lower. Furthermore, TLR4 expression levels in
children with primary ABU is lower than in children with
secondary ABU [13]. However, there is still a lack of information
on the relationship of TLR4 expression and other types of UTI.
The results of this study show that TLR4 expression in patients
with chronic UTI is significantly lower than that in the control and
acute pyelonephritis groups, suggesting that chronic UTI can be
the result of reduced TLR4 expression, thereby effectively
inducing innate immune response.
TLR4 determines the efficiency of bacteria identification, but
chemokine receptors are the ones that affect clearing of bacteria
[24]. Defects in expression of IL-8 receptors CXCR1 and CXCR2
have been associated with many infectious diseases, particularly
acute pyelonephritis. Mice lacking the CXCR1 homologue Mcxcr
2 frequently have acute pyelonephritis with bladder infection. As
bacteria numbers increase, bacteremia prevalence and mortality
Figure 2. The drawing of CXCR1 detected by FCM on neutrophils of UTI patients. A:health controls; B:acute pyelonephritis; C:chronical UTI.
doi:10.1371/journal.pone.0014223.g002
Figure 3. Expression of CXCR1 on monocytes of different type
of UTI.
doi:10.1371/journal.pone.0014223.g003
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expression in pyelonephritis-prone children is lower than that in
the control group, and CXCR1 expression level in children with
UTI is significantly lower than that in the control group [8,14].
The results of this study show that the prevalence frequencies of
CXCR1 (2608) GC and CXCR1 (2608) C in UTI patients and
patients with chronic UTI are lower than those in the healthy and
acute cystitis groups, but expression levels of CXCR1 in
neutrophils were not different. These results indicate polymor-
phism of CXCR1 G(2608)C was associated with protection from
UTIs in adults, especialy from chronical UTIs.
The over use of broad spectrum antibiotics has led to the
emergence of antibiotic resistant bacteria. As a consequence, the
treatment of UTIs especially chronic UTIs becomes a very difficult
clinical problem. Modulating the powerful innate and adaptive
immune systems of the urinary tract would have important
therapeutic and prophylactic implications for the treatment of
UTIs, particularly treatment of antibiotics alone is ineffective.
Since the lining of the urinary tract is highly enrichedin TLR4
molecules, administering TLR4 specific ligands directly to the
urinary tract could trigger TLR4 mediated innate immune
responses thereby enhancing local reactivity and resistance to
infection [24]. In present many immunomodulator were used in
clinical treatment of UTI or animal experemen, such as thymosin,
astragalus and ligands of TLR4. Although we have not known the
mechanism, their use benefit in the urinary tract. APS is an agonist
for TLR4 receptor, and it is antagonistic in a case of coexistence of
LPS [25]. And we have demonstrated that APS was effective in
Figure 4. Expression of TLR4 on monocytes of pre-or post-treatment of chronic UTI. A: The percent of TLR4 expression on monocytes of
pre-or post-treatment of chronic UTI. B: The drawing of TLR4 detected by FCM on monocytes of pre-or post-treatment of chronic UTI. B1: Pre-
treatment by astralagus; B2: post-treatment by astralagus.
doi:10.1371/journal.pone.0014223.g004
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activity of bladder epithelial cells(BECs) [16]. In this study, we
applicated astragalus injection and antibiotics simultaneously to
treat chronic UTI patients, the TLR4 expression levels on
monocytes in the patients increased after recovery. Thus we think
that astragalus as an immunomodulator enhanced TLR4
expression and thereby increased the innate immune capability
of patients with chronic UTI and promoted clearance of infection.
In conclusion, the TLR4A (896) G genotype was found to be
associated with adult UTi, especially acute urethritis. TLR4
expression in the mononuclear cells of patients with chronic UTI
was significantly reduced. Thus, TLR4 gene and expression tests
can be used as auxiliary indicators for the diagnosis and treatment
of UTI. With the increase of antibiotic resistance, the therapy of
UTI patients can be supplemented with immunomodulators for
improved results. The results of this study could provide reliable
clinical evidence for the development and research of drugs
targeting TLR4 for UTI treatment.
Materials and Methods
Patients
The study protocols were approved by Ethics committiee of
Bthune International Peace Hospital Shijiazhuang City, Heibei
Province, China. The different types of UTI included in this study
are acute pyelonephritis (32 cases), chronic UTI (38 cases), and
acute cystitis and urethritis (59 cases). Acute pyelonephritis were
defined as a febrile infection (§38.5uC) with significant bacteri-
uria, Creactive protein .20 mg/l and lack of symptoms of other
infections. Acute cystitis and urethritis subjects were defined that
patients appeared obvious irritative symptoms of bladder with
bacteriuria or blood urine. Chronic UTI subjects were defined as a
UTI episode within a 12-month time frame or 2 UTIs within 6
months. After obtaining their consent, blood samples were
collected from 129 patients (104 women/25 men, age: 19–80y)
with UTI at the Department of Nephrology, Bethune Interna-
tional Peace Hospital.
Healthy controls
Health controls were enrolled and came from Bethune
International Peace Hospital and verified to have no infectious
disease history. There were 248 health controls (202women/
46men) aged 20–70 years. After gaining their consent, blood
samples were drawn for the tests.
Samples and genotyping
Genomic DNA was extracted from whole blood samples using
blood DNA extraction kit (Qiangen) according to the manufac-
turer’s instructions. TLR4 A (896) G and CXCR1 G (2608) C
genotypes were detected by RFLP-PCR as previously described
[10,26].
Astragalus treatment of chronic UTI patients
Astragalus injection was purchased from Shanghai Fuda
Pharmaceuticals Company. 20 patients with chronic UTI were
selected to receive parenteral astralagus treatment. Each patient
received 500 mg/kg/d astralagus intravenously for 1 or 2 weeks.
At the same time they were injected antibiotics by same
approachs. Antibiotics used included cefoperazone/sulbactarm(4
cases), cefotiam(6 cases), cefuroxime(4 cases), mezlocillin/sulbac-
tarm(5 cases) and imipenem(1 case). Their TLR4 expression levels
on monocytes were detected before and after treatment.
Flow cytometry
TLR4 and CXCR1 protein expression was detected by flow
cytometry. Three groups were detected: acute pyelonephritis
patients, chronic UTI and health controls. There are 20 cases in
each group. Monocytes and neutrophils were incubated for
30 min with PE- and FITC-labeled monoclonal antibodies against
human TLR4 and CXCR1 (CD181) (BioLegend, USA), respec-
tively. After washing with PBS, the stained cells were run on a flow
cytometer (Beckman Coulter, USA). The percentage of TLR4 and
CXCR1 was counted.
Statistical analysis
Data were analyzed using SPSS13.0 software. Statistical
significance was calculated by X
2 test and t-test. Significance was
set at p,0.05.
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